References
- Broadus A E, Hardman J G, Kaminsky N I, Ball J H, Sutherland E W, Liddie G W. Extracellular cyclic nucleotides. Ann NY Acad Sci 1971; 185: 50–65
- Murad F, Pak C YC. Urinary excretion of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate. N Engl J Med 1972; 286: 1382–7
- Guthrie D, Isah H, Latner A L, Turner G A. Urine cyclic GMP a possible biochemical marker for cancer. IRCS Med Sci 1979; 7: 209
- Chawla R K, Shlaer S M, Lawson D H, et al. Elevated plasma and urinary guanosine 3′:5′-monophosphate and increased production rate in patients with neoplastic diseases. Cancer Res 1980; 40: 3915–20
- Hunt N H, Smith B, Pembrey R. Cyclic nucleotide excretion in human malignancies. Clin Sci 1980; 58: 463–7
- Duttagupta C, Romney S L, Palan P R, Slagle N S. Urinary cyclic nucleotides and the cytopathology of human uterine cervical dysplasias. Cancer Res 1982; 42: 2938–43
- Tuner G A, Ellis R D, Guthrie D, et al. Urine cyclic nuclmtide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment. J Clin Pathol 1982; 35: 800–6
- Luesley D M, Blackledge G R, Chan K K, Newton J R. Random urinary cyclic 3′,5′ guanosine mono-phosphate in epithelial ovarian cancer: relation to other prognostic variables and to survival. Br J Obstet Gynaecol 1986; 93(4)380–5
- Luesley D M, Chan K K, Newton J R, Blackledge G R. Serial urinary cyclic guanosine monophosphate measurements in the assessment of response to treatment in epithelial ovarian cancer. Br J Obstet Gynaecol 1987; 94(5)461–6
- Vorderwinkler K P, Artner-Dworzak E, Jakob G, et al. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases. Clin Chem 1991; 37(2)186–90
- Abraham W T, Hensen J, Kim J K, et al. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure. J Am Soc Nephrol 1992; 2(12)1697–703
- Zheng X, Ma S J, Zhang T H, Chen S C. Plasma levels of cyclic nucleotides in chronic congestive heart failure and their clinical implication. Int J Cardiol 1993; 40(1)7–15
- Jakob G, Mair J, Vorderwinkler K P, et al. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure. Clin Chem 1994; 40(1)96–100
- Hamet P, Pang S C, Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 1989; 264: 12364–9
- Kapoor C L, Krishna G. Hormone-induced cyclic guanosine monophosphate secretion from guinea pig pancreatic lobules. Science 1977; 196: 1003–5
- Tjornhammar M-L, Lazaridis G, Bartfai T. Cyclic GMP efflux from liver slices. J Biol Chem 1983; 258: 6882–6
- Ørbo A, Jaeger R, Sager G. Effect of serum and cell density on transmembrane distribution of CAMP and cGMP in transformed (C4-I) and non-transformed (WI-38) human cells. Int J Cancer 1993; 55: 957–62
- Steck T L, Weinstein R S, Straus J H, Wallach D FH. Inside-out cell membrane vesicles: preparation and purification. Science 1970; 168: 255–7
- Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976; 72: 248–54
- Billiar T R, Curran R D, Harbrecht B G, et al. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am J Physiol 1992; 262: C1077–82
- Odea R F, Gagnon C, Zatz M. Regulation of guanosine 3′,5′ cyclic monophosphate in the rat pineal and posterior pituitary glands. J Neurochem 1978; 31: 733–8
- Tjörnhammar M-L, Lazaridis G, Bartfai T. Efflux of cyclic guanosine 3′,5′-monophosphate from cerebellar slices stimulated by L-glutamate or high K+ or N-methyl-N′-nitro-N-nitrosguanidine. Neurosci Lett 1986; 68: 95–9
- Kondo T, Dale G L, Beutler E. Glutathione transport by inside-out vesicles from human erythrocytes. Proc Natl Acad Sci USA 1980; 77: 6359–62
- Kondo T, Dale G L, Beutler E. Studies on glu-thathione transport utilizing inside-out vesicles prepared from human erythrocytes. Biochim Biophys Acta 1981; 645: 132–6
- Higgins C F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992; 8: 67–113
- Beavo J. Multiple phosphodiesterase isoenzymes—background, nomenclature and implications. Cyclic nucleotide phosphodiesterases: structure, regulation and drug action, J Beavo, M D Houslay. John Wiley, Chichester 1990; vol 2: 3–15
- Torphy T J, Cieslinski L B. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Mol Pharmacol 1990; 37(2)206–14